LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

Search

Option Care Health Inc

Затворен

СекторЗдравеопазване

32.46 -1.49

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

32.29

Максимум

32.89

Ключови измерители

By Trading Economics

Приходи

1.3M

52M

Продажби

19M

1.4B

P/E

Средно за сектора

26.619

76.798

EPS

0.45

Марж на печалбата

3.611

Служители

8,000

EBITDA

53M

156M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+11.01% upside

Пазарни показатели

By TradingEconomics

Пазарна капитализация

914M

5.4B

Предишно отваряне

33.95

Предишно затваряне

32.46

Настроения в новините

By Acuity

50%

50%

167 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

Option Care Health Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

18.12.2025 г., 23:54 ч. UTC

Горещи акции

Stocks to Watch: Nike, Cassava Sciences, KB Home

18.12.2025 г., 23:51 ч. UTC

Печалби

Nike Sales Tick Up in 2Q; China Weakness Persists -- Update

18.12.2025 г., 23:39 ч. UTC

Значими двигатели на пазара

Cassava Sciences Shares Fall After FDA Places Hold on Epilepsy Drug Trial

18.12.2025 г., 22:57 ч. UTC

Придобивния, сливания и поглъщания

TikTok Signs Agreement for Sale of U.S. Unit, Axios Reports, Citing a Memo

18.12.2025 г., 21:40 ч. UTC

Печалби

Nike Sales Tick Up, But China Weakness Persists

18.12.2025 г., 23:45 ч. UTC

Пазарно говорене

Gold Steady, Supported by Fed Rate-Cut Prospects -- Market Talk

18.12.2025 г., 23:37 ч. UTC

Пазарно говорене
Печалби

Nike 2Q Results Fail to Convince Investors of Recovery -- Market Talk

18.12.2025 г., 23:36 ч. UTC

Пазарно говорене

Nikkei May Rise, Tracking Wall Street's Rally -- Market Talk

18.12.2025 г., 23:03 ч. UTC

Придобивния, сливания и поглъщания

Mitsubishi Materials: Impact on Consolidated Results for FY Ending March 2026 Likely to be Immaterial

18.12.2025 г., 23:02 ч. UTC

Придобивния, сливания и поглъщания

Mitsubishi Materials: To Acquire 4,448 Common Shares, 13,771 Preferred Shares of Co.

18.12.2025 г., 23:00 ч. UTC

Придобивния, сливания и поглъщания

Mitsubishi Materials: Investment to Strengthen Recovery Network in U.S.

18.12.2025 г., 22:59 ч. UTC

Придобивния, сливания и поглъщания

Mitsubishi Materials: Investment to Contribute to Expanding Collection Volume of Secondary Raw Material

18.12.2025 г., 22:58 ч. UTC

Придобивния, сливания и поглъщания

SpaceX Could Go Public by Merging With EchoStar. It Isn't a Crazy Idea. -- Barrons.com

18.12.2025 г., 22:57 ч. UTC

Придобивния, сливания и поглъщания

Mitsubishi Materials: Elemental USA E-Waste Operates E-Waste Recycling Business in U.S.

18.12.2025 г., 22:56 ч. UTC

Придобивния, сливания и поглъщания

Mitsubishi Materials: To Acquire Portion of Shares of Elemental USA E-Waste & ITAD

18.12.2025 г., 22:55 ч. UTC

Печалби

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18.12.2025 г., 21:59 ч. UTC

Печалби

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18.12.2025 г., 21:50 ч. UTC

Пазарно говорене
Печалби

Tech, Media & Telecom Roundup: Market Talk

18.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

18.12.2025 г., 21:35 ч. UTC

Печалби

FedEx's Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

18.12.2025 г., 21:31 ч. UTC

Печалби

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18.12.2025 г., 21:15 ч. UTC

Печалби

Nike 2Q Europe, Middle East & Africa Rev $3.39B >NKE

18.12.2025 г., 21:15 ч. UTC

Печалби

Nike 2Q Greater China Rev Down 17% >NKE

18.12.2025 г., 21:15 ч. UTC

Печалби

Nike 2Q EPS 53c >NKE

18.12.2025 г., 21:15 ч. UTC

Печалби

Nike 2Q Apparel Rev $3.91B >NKE

18.12.2025 г., 21:15 ч. UTC

Печалби

Nike 2Q Equipment Rev $550M >NKE

18.12.2025 г., 21:15 ч. UTC

Печалби

Nike 2Q N Amer Rev $5.63B >NKE

18.12.2025 г., 21:15 ч. UTC

Печалби

Nike 2Q Footwear Rev $7.66B >NKE

18.12.2025 г., 21:15 ч. UTC

Печалби

Nike 2Q Asia Pacific & Latin America Rev Down 4% >NKE

18.12.2025 г., 21:15 ч. UTC

Печалби

Nike 2Q Greater China Rev $1.42B >NKE

Сравнение с други в отрасъла

Ценова промяна

Option Care Health Inc Прогноза

Ценова цел

By TipRanks

11.01% нагоре

12-месечна прогноза

Среден 36.6 USD  11.01%

Висок 40 USD

Нисък 27 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за Option Care Health Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

11 ratings

10

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

31.11 / 32.41Подкрепа & съпротива

Краткосрочен план

Bearish Evidence

Средносрочен план

Neutral Evidence

Дългосрочен план

Strong Bullish Evidence

Настроение

By Acuity

167 / 374 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Option Care Health Inc

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
help-icon Live chat